semaglutide and gastric emptying GLP-1 receptor agonists like (Ozempic, Wegovy) tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These Ozempic & Stomach Problems |

For individuals who may need a more potent option, Zepbound in Coeur d'Alene could be your answer

The interaction between these substances could lead to unpredictable effects on blood sugar levels and overall health

Sources [1]Ozempic (semaglutide): EMA EPAR, centralised authorisation for type-2 diabetesTier 1 primary [2]EMA: Ferrer Internacional withdraws marketing-authorisation application for Egrifta (tesamorelin), 26 June 2012Tier 1 primary [3]Wilding et al

When facial fat (the good type!) diminishes rapidly, the skin may not have sufficient time to recover its elasticity

Knezevic et al., 2021b

On the other hand, these observed increases were significantly reduced in mice treated with SEMA along with TAA